Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Optiscan Imaging Limited ( (AU:OIL) ) has issued an update.
Optiscan Imaging Limited has successfully completed the Minimum Viable Product (MVP) stage of its cloud-based telepathology software, developed in collaboration with Prolucid Technologies. This advancement allows real-time digital pathology imaging and collaboration, breaking geographical barriers and enhancing decision-making in healthcare, particularly in remote settings. The platform ensures secure, encrypted data handling and aims to transform digital pathology by enabling remote access to high-resolution images, facilitating immediate, informed decisions at the point of care.
More about Optiscan Imaging Limited
Optiscan Imaging Limited is a company in the medical imaging industry, focusing on developing advanced imaging solutions. Their primary products include a suite of medical devices such as InVue®, InForm™, and InVivage®, with a market focus on enhancing digital pathology and telepathology capabilities.
Average Trading Volume: 172,709
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$96.06M
For detailed information about OIL stock, go to TipRanks’ Stock Analysis page.